Dna X (SONM) Receivables - Other (2020 - 2025)
Dna X (SONM) has disclosed Receivables - Other for 6 consecutive years, with $9.8 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Receivables - Other rose 127.7% year-over-year to $9.8 million, compared with a TTM value of $9.8 million through Sep 2025, up 127.7%, and an annual FY2024 reading of $7.1 million, up 640.79% over the prior year.
- Receivables - Other was $9.8 million for Q3 2025 at Dna X, up from $7.0 million in the prior quarter.
- Across five years, Receivables - Other topped out at $9.8 million in Q3 2025 and bottomed at $890000.0 in Q3 2022.
- Average Receivables - Other over 5 years is $3.7 million, with a median of $2.7 million recorded in 2021.
- The sharpest move saw Receivables - Other plummeted 71.65% in 2022, then surged 640.79% in 2024.
- Year by year, Receivables - Other stood at $2.3 million in 2021, then grew by 0.62% to $2.3 million in 2022, then crashed by 57.65% to $961000.0 in 2023, then soared by 640.79% to $7.1 million in 2024, then skyrocketed by 38.24% to $9.8 million in 2025.
- Business Quant data shows Receivables - Other for SONM at $9.8 million in Q3 2025, $7.0 million in Q2 2025, and $6.5 million in Q1 2025.